AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Arctic Fish Holding

Annual Report Feb 12, 2025

3537_rns_2025-02-12_cd5bf552-a141-45c9-9f58-9e4d11252a85.pdf

Annual Report

Open in Viewer

Opens in native device viewer

Q4|2024 Report 12 February 2025

Highlights Q4 2024 2
Principal activities 3
Q4 2024 Performance 4
Outlook 6
Board Declaration 9
Consolidated Income Statement 10
Statement of Financial Position 11
Statement of Equity 12
Statement of Cash Flow 13
Note 1 General Information 14
Note 2 Accounting Principles 15
Note 3 Estimates and Risk Exposure 16
Note 4 Biological Assets 17
Note 5 Financial Items 18
Note 6 Share Capital 19
Note 7 Shareholders 20
Note 8 Share Price Development 21

Highlights Q4 2024

  • 2024 resulted in the highest operational EBIT in the history of the company and a profitable bottom line for the year.
  • Harvested quantities in the quarter amounted to 3,456 tonnes compared to 2,529 tonnes during the same period last year.
  • Operational EBIT pr. kg in the quarter amounted to 0.61 EUR pr. kg compared to 1.65 EUR pr. kg last year.
  • Biological development and growth in Q4 developed as expected.
  • The company has announced a volume target of 25.000 tonnes within 2029. Sufficient smolt capacity is secured through internal smolt production and external smolt agreements.
Harvested quantities in the quarter amounted to 3,456 tonnes compared
to 2,529 tonnes during the same period last year.
compared to 1.65 EUR pr. kg last year. Operational EBIT pr. kg in the quarter amounted to 0.61 EUR pr. kg
Biological development and growth in Q4 developed as expected.
The company has announced a volume target of 25.000 tonnes within
2029.
Sufficient
smolt
production and external smolt agreements.
capacity
is
secured
through
internal smolt
(EUR '000) Q4 2024 Q4 2023 2024 2023
Operational revenue & other income 24.481 18.960 80.902 88.900
Operational EBITDA 4.383 6.208 23.794 21.239
Operational EBIT 2.121 4.174 15.105 14.493
114.289 132.650 114.289
Net interest-bearing debt (NIBD) 132.650
Underlying EPS (EUR) 0,05 0,14 0,45 0,59
Net cash flow per share (EUR) 0,12 -0,30 -0,26 -1,14
ROCE
Equity ratio
4,3%
35,4%
9,7%
38,0%
7,8%
35,4%
8,5%
38,0%
Harvest volume (GWT) 3.456 2.529 10.667 11.878

Principal activities

The Group's principal activity is salmon farming, producing smolt in its own freshwater hatchery and farming salmon at sea before the fish is harvested and finally sold to the market.

Freshwater smolt

The Group has a modern freshwater hatchery and smolt facility in Norðurbotn (Tálknafjörður), using RAS technology. The Group owns a 36.3 km2 land area surrounding the facility and securing existing and future expansion with both sufficient land and water capacity.

Seawater sites

The Group's production capacity for the company is 29,800 tonnes MAB (Maximum Allowed Biomass) and includes licenses covering 10 farming areas in 5 different fjords, all located in the Westfjords of Iceland. This structure enables alternation of production areas to minimize biological risk. The sites are in general considered with high bearing capacity indicated by low and non-impact proven by regular bottom surveys. The Group currently holds licenses for a production of the 29,800 tonnes thereof 27,000 tonnes for fertile salmon.

Processing

All processing of the Group's salmon since Q3'2023 and onwards takes place in the company's brand-new, state of the art harvesting facility in Bolungarvík. The facility has been designed to fulfil the short and long-term needs of Arctic Fish, with extension and growth possibilities for external service contracts for other farmers.

Sales

The fish is sold through a sales agreement with Mowi. The Group sees substantial potential in utilizing the synergies from the majority owner Mowi with sales being handled by Mowi from September 2023 and onwards.

Market routes both domestically and internationally are developing positively, and there is potential to enter markets and costumers efficiently.

Q4 2024 Performance

The fourth quarter's performance will be broken down into the main operating categories, investments, and financing. In brackets some historical performance for the year 2023 is provided.

Key financial Performance

(Figures in brackets = 2023, unless otherwise specified)

Revenues and results

Revenues amounted to 24.5 MEUR in the quarter, compared to 19.0 MEUR in the corresponding prior-year period, the difference can be traced to volume differences and price achievement variance.

The Group achieved a positive operational EBIT of EUR 2.1 million (Q4'2023: EUR 4.2 million)

The sold volume HOG was 3,456 tonnes in the quarter, compared to 2,529 tonnes harvested in the same respective period last year.

The Group recognised a positive fair value adjustment of EUR 4.5 million (Q4'2023: EUR 0.3 million) on the biomass in sea, an increase of EUR 4.2 million compared to the corresponding quarter in 2023. The higher fair value adjustment in the quarter can largely be attributed to more biomass in sea and more favourable average weights for the fair value adjustment.

Financial items

Net financial losses were EUR -2.7 million in the quarter (Q4'2023: EUR -2.3 million). Net interest payments in the quarter amounted to 2.6 million EUR in the period, whilst other financial items amounted to 0.1 million in losses.

Balance sheet

At the end of the fourth quarter 2024, total assets amounted to EUR 249.9 million, which is an increase of EUR 11.9 million from the prior period (Q3'2024). The increase is mainly due to increasing biological assets.

Net interest bearing debt

Net interest-bearing debt has decreased from quarter over quarter as a result of positive operational cash flow, mainly related to working capital release since the fourth quarter has a lower biomass build-up as a result of biological seasonality.

The financial items also contribute to the increase in NIBD, with the net change in the quarter amounting to a reduction of EUR 1.3 million.

Equity

At the end of the reporting period, the Group's equity totalled EUR 88.4 million, an increase of EUR 1.2 million from the end of the previous quarter. The equity ratio at the end of the quarter amounted to 35.4%, which is a decrease of 1.2% from the previous quarter.

Seawater

Biological development and growth in Q4 developed as expected.

Smolt production

Biological performance in the quarter was fundamentally solid. The company has also managed to finalize external smolt agreements to secure growth objectives for 2025.

Outlook

Markets and sales

Harvesting volumes in 2024 amounted to 10.7 thousand tonnes, and therefore exceeded the volumes set forth in earlier forecasts.

Guidance for 2025 is set at 15 thousand tonnes (HOG), which amounts to a 40% increase year over year.

Investments

CAPEX was minimal in the quarter as was the intention. Minor investments were made in farming and other smaller production based equipment.

Increased internal smolt production expansion to secure capacity is in progress, and the result of which is to secure capacity for the long-term plans of achieving the 25,000 tonnes target.

Licenses

The total production capacity for the company after the license update is 29,800 tonnes MAB (Maximum Allowed Biomass) and includes licenses covering 10 farming areas in 5 different fjords, all located in the Westfjords of Iceland. Of the 29,800 tonnes, 27,000 tonnes are for fertile salmon.

Additionally, the Group holds a license for land-based smolt production on its own property in Norðurbotn, with a current annual production capacity of 1,000 tonnes. The Group has initiated the process and application to increase this capacity to 2,400 tonnes.

Production capacity SW (tonnes)

Board Declaration

Responsibility statement from the board of directors and CEO

We confirm, to the best of our knowledge, that the financial report for the fourth quarter of 2024 has been prepared in accordance with IAS 34 – Interim Financial Reporting, as adopted by EU, and gives a true and fair view of the Group's assets, liabilities, financial position and profits and loss for the period. Furthermore, we confirm that the interim management report includes a fair view of the information required under the Norwegian Securities Trading Act § 5-6, fourth paragraph.

10.02.2025

The Board of Directors of Arctic Fish Holding AS

Øyvind Oaland

Chairman

Ivan Vindheim Board member

Gunnþór Ingvason Board member

Gunnar Atli Gunnarsson Board member

Hildur Árnadóttir Board member

The Management of Arctic Fish Holding AS

Stein Ove Tveiten CEO

Baldur Smári Einarsson CFO

Consolidated Income Statement

Q4 2024
Consolidated Income Statement
(EUR '000) Q4 2024 Q4 2023 2024 2023
Revenue 24.481 18.960 80.902 88.900
Cost of materials -13.662 -7.794 -33.285 -45.019
Net fair value adjustment biomass 4.492 271 3.940 -412
Salaries and personnel expenses -3.115 -2.872 -10.772 -9.397
Other operating expenses -3.322 -2.086 -13.051 -13.245
Depreciation and amortisation -2.262 -2.034 -8.688 -6.745
License and production fees / taxes -891 -310 -2.704 -1.473
Restructuring costs -1.202 -137 -2.238 -16.456
Impairment losses and write-downs -790
Earnings before financial items (EBIT) 4.519 3.998 14.103 -4.638
Interest expenses -2.573 -2.879 -10.204 -9.543
Net currency effects -188 273 -742 -2.250
Other financial items 50 300 354 243
Earnings before tax 1.808 1.692 3.511 -16.188
Income taxes -556 -264 -896 3.312
Profit or loss for the period 1.252 1.428 2.615 -12.876
Total comprehensive income for the
period attributable to
Owners of Arctic Fish Holding AS 1.252 1.428 2.615 -12.876
0,04 0,04 0,08

Statement of Financial Position

Q4 2024
Statement of Financial Position
(EUR '000) 31.12.2024 30.9.2024 30.9.2023 31.12.2023
Assets
Farming licenses 5.996 5.861 5.167 5.364
Goodwill 658 658 658 658
Deferred tax assets 3.071 3.574 4.178 3.914
Other intangible assets 255 273 343 325
Property, plant & equipment 127.656 128.170 124.661 128.198
Other shares and other non-current assets 62 62 62 62
Total non current assets 137.699 138.597 135.068 138.520
Inventory 5.007 3.696 1.906 2.372
Biological assets 98.721 91.687 53.052 65.903
Current receivables 4.484 1.166 19.415 6.519
Cash 4.006 2.910 6.113 12.316
Total current assets 112.218 99.458 80.486 87.110
Total assets 249.917 238.055 215.554 225.630
Equity and liabilities
Equity 88.355 87.103 84.311 85.739
Total equity 88.355 87.103 84.311 85.739
Deferred tax liability
Non current interest bearing debt 136.657 136.835 69.981 126.605
Non current leasing liabilities 200 137 263 194
Total non current liabilities 136.856 136.972 70.244 126.799
Current interest bearing debt 38.453
Current leasing liabilities 184 95 91 95
Other current liabilities 24.521 13.885 22.456 12.998
Total current liabilities 24.705 13.980 61.000 13.093
215.554
Total equity and liabilities 249.917 238.055 225.630

Statement of Equity

(EUR '000) Share capital Other paid in capital Other equity reserves Total equity
Equity 01.01.2024 3.032 95.281 -12.572 85.741
Comprehensive income 2.615 2.615
Transactions with owners
Total Equity end of period 3.032 95.281 -9.958 88.352
(EUR '000) Share capital Other paid in capital Other equily reserves Total equity
Equity 01.01.2023 3.032 95.281 302 98.615
Comprehensive income -12876 -12.876
Transactions with owners
Total Equity 31.12.2023 3.032 95.281 -12.574 85.739

Statement of Cash Flow

Statement of Cash Flow Q4 2024
(EUR '000) Q4 2024 Q4 2023 2024 2023
1.808 1.692 3.511 -16.188
Earnings before tax 2.573 2.879 10.204 9.543
Interest expense 188 -273 742 2.250
Net currency effect
Other financial item(s)
-50 -300 -354 -243
-4.492 -271 -3.940 412
Net fair value adjustment and onerous contracts
Impairment losses, depreciation and amotization
2.262 2.034 8.688 7.535
Change in inventory, trade payables and trade receivables 3.538 -10.029 -18.092 -697
Taxes paid -53
Cash flow from operations 5.827 -4.268 706 2.612
Purchase of fixed assets and additions to intangible assets -1.867 -5.749 -8.710 -36.865
Cash flow from investments -1.867 -5.749 -8.710 -36.865
Net proceeds from new interest-bearing debt -255 126.756
-108.582
9.745 164.332
-116.229
Downpayments interest bearing debt 152 -65 94 -88
Downpayment leasing debt -2.520 -2.159 -9.405 -8.323
Net interest and financial items paid
Currency effects
-188 271 -740 -2.248
Cash flow from financing -2.810 16.221 -306 37.442
Change in cash in the period 1.097 6.203 -8.309 3.189
Cash - opening balance 2.910 6.113 12.316 9.126
Cash - closing balance 4.006 12.316 4.006 12.316

Selected notes to the Interim Financial Statements

Note 1 General Information

Arctic Fish Holding AS and its subsidiaries (collectively "the Group", or "Arctic Fish Group") is a publicly listed company on Euronext Growth, with the ticker symbol AFISH.

Arctic Fish Holding AS is a Company incorporated in Norway with headquarters in Iceland. Arctic Fish´s headquarter is located at Sindragata 10, 400 Isafjordur, Iceland.

The consolidated financial statements of the Group were authorised for issue in accordance with a resolution of the Board of Directors.

Note 2 Accounting Principles

The structure of the Group was changed in 2021. Arctic Fish Holding AS is a newly established entity that owns 100% of the shares in Arctic Fish ehf. the Icelandic mother company of the Icelandic subsidiaries Arctic Oddi, Arctic Smolt and Arctic Sea Farm.

In the consolidated financial statements of Arctic Fish Group the values of Arctic Fish Iceland and subsidiaries are continued. The Group has accounted for the reorganization as a continuation of Arctic Fish ehf. The consolidated financial statements are presented as if the Group and Arctic Fish Holding AS as the parent company, had always existed.

Comparative financial information is provided for the preceding period in the Consolidated statement of comprehensive income, Consolidated statement of financial position and Consolidated statement of cash flows.

These condensed, consolidated interim financial statements have been drawn up in accordance with International Financial Reporting Standards (IFRSs) and such interpretations as are determined by the EU and published by the International Accounting Standards Board, including the interim reporting standard (IAS 34). The interim financial statements do not include all the information required of an annual financial report.

The condensed consolidated interim financial statements have not been audited. As a result of rounding differences, numbers or percentages may not add up to the total.

The consolidated financial statements are presented in EUR which is the functional currency of the Group since 01.07.2023 where the Group converted the operational currency to Euros (EUR) from Norwegian Kroner (NOK).

Note 3 Estimates and Risk Exposure

The preparation of financial statements in accordance with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting principles and recognised amounts of assets, liabilities, income and expenses. The most significant estimates relate to the valuation of biological assets. Estimates and underlying assumptions are reviewed on an ongoing basis and are based on the management's best assessment at the time of reporting. All changes in estimates are reflected in the financial statements as they occur.

Arctic Fish is exposed to a number of risk factors: Operational risks, licenses, legal and regulatory framework and financial risk. The "Operational risk and risk management" section in the Annual Report contains a detailed description of risks and mitigation actions.

Note 4 Biological Assets

(EUR '000) TOTAL
Net fair value adjustment biomass in the statement of comprehensive income
Q4 2024 4.492
Q4 2023 271
2024 3.940
2023 -412
Volumes of biomass in sea (tonnes)
31 December 2024 13.768
30 September 2024 13.112
31 December 2023 11.375
Fair value adjustment on biological assets in the statement of financial position
31 December 2024
Fair value adjustment on biological assets 18.765
Cost on stock for fish in sea 76.012
Cost on stock for freshwater and cleanerfish 3.944
Total biological assets 98.721
30 September 2024
Fair value adjustment on biological assets 14.273
Cost on stock for fish in sea 74.104
Cost on stock for freshwater and cleanerfish 3.310
Total biological assets 91.687
31 December 2023
Fair value adjustment on biological assets 14.825
Cost on stock for fish in sea 46.607
Cost on stock for freshwater and cleanerfish 4.471
Total biological assets 65.903

Note 5 Financial Items

(EUR '000) Q4 2024 Q4 2023 2024 2023
Interest expenses -2.562 -2.876 -10.187 -9.528
Interest expenses leasing (IFRS 16) -11 -4 -16 -15
Net interest expenses -2.573 -2.879 -10.204 -9.543
Net currency effect on long term positions 3 -2
Net currency effects on short term positions -173 237 -727 -2.245
Net currency effects on short term currency hedges
Currency effects on leasing (IFRS 16) -15 34 -15 -4
Net currency effects -188 273 -742 -2.250
Net other financial items 50 300 354 243
Other financial items 50 300 354 243
Net financial items -2.711 -2.306 -10.592 -11.550

Note 6 Share Capital

Q4 2024
Note 6
Share Capital
(EUR '000)
Share capital
No. of shares Share capital Other paid in capital
Issued at the beginning of 2024 31.876.653 3.032 82.709
Changes during the period 0 0 2.615

Note 7 Shareholders

Major shareholders as of 31.12.2024:

Name of shareholder No. of shares %
MOWI ASA 16.346.824 51,28%
Síldarvinnslan hf.** 10.899.684 34,19%
J.P. Morgan SE ** 2.218.998 6,96%
Landsbankinn hf. 502.920 1,58%
Íslandsbanki hf. 281.976 0,88%
KVERVA FINANS AS 223.776 0,70%
State Street Bank and Trust Comp 175.000 0,55%
VERDIPAPIRFONDET EIKA SPAR 167.406 0,53%
MP PENSJON PK 165.000 0,52%
PACTUM AS 150.701 0,47%
CLEARSTREAM BANKING S.A. 140.344 0,44%
VERDIPAPIRFONDET EIKA NORGE 121.659 0,38%
ROTH 80.000 0,25%
RAMSFJELL AS 40.849 0,13%
Saxo Bank A/S 37.168 0,12%
VERDIPAPIRFONDET EIKA ALPHA 33.705 0,11%
DNB Luxembourg S.A. 25.231 0,08%
VERDIPAPIRFONDET EIKA BALANSERT 18.432 0,06%
HØSTLUND 18.000 0,06%
HATLEBREKKE INVEST AS 16.700 0,05%
STEINERUD AS 16.700 0,05%
Total 20 largest shareholders 31.681.073 99,39%
Total other 195.580 0,61%
Total number of shares 31.12.2024 31.876.653 100,00%

20 largest shareholders list includes nominee accounts that are composed of multiple individual shareholders.

**Síldarvinnslan hf is a part of the nominee account "J.P. Morgan SE".

Arctic Fish Holding AS does not own any of its own shares.

Note 8 Share Price Development

Share price development at Euronext Growth (ticker AFISH)

Forward looking statements

This quarterly report includes forward-looking statements that reflect the Company's current views with respect to future events and financial and operational performance. These forward-looking statements may be identified by the use of forward-looking terminology. These forward-looking statements are not historic facts. The forward-looking statements are not guarantees of future performance. The Company's actual financial position, operating results and liquidity, and the development of the industry in which the Company operates, may differ materially from those made in, or suggested, by the forward-looking statements. The Company cannot guarantee that the intentions, beliefs, or current expectations upon which its forward-looking statements are based will occur. By their nature, forward-looking statements involve, and are subject to, known and unknown risks, uncertainties, and assumptions as they relate to events and depend on circumstances that may or may not occur in the future. Because of these known and unknown risks, uncertainties and assumptions, the outcome may differ materially from those set out in the forward-looking statements. These forward-looking statements speak only as at the date on which they are made. The Company undertakes no obligation to publicly update or publicly revise any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent written and oral forwardlooking statements attributable to the Company or to persons acting on the Company's behalf are expressly qualified in their entirety by the cautionary statements referred to above and contained elsewhere in this report.

Q4|2024 Report

Q4|2024

Talk to a Data Expert

Have a question? We'll get back to you promptly.